In a transplant patient who has developed numerous of these lesions requiring Mohs, discussion with the patients transplant team regarding switching to which of the following medications may reduce risk deloping more of these in the future?

A. Sirolimus

B. Cyclosporine

C. Azathioprine

D. Voriconazole

E. Methotrexate

To find out the correct answer and read the explanation, click here.

The image is from  The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas.

Brought to you by our brand partner 

 

*Brand partners had no involvement in the content of the questions or answers.